HeartBeam, Inc.
HeartBeam, Inc.
Your view on BEATW
Overview
What the company does, where it operates, and who runs it.
About HeartBeam, Inc.
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Branislav Vajdic
- Headquarters
- 2118 Walsh Avenue, Santa Clara, CA, US
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Branislav Vajdic
- Headquarters
- 2118 Walsh Avenue, Santa Clara, CA, US
HeartBeam, Inc. is an emerging enterprise concentrating on innovative cardiovascular diagnostic technology. The company has developed an electrocardiogram (ECG) collection device specifically designed to gather critical heart health data from patients remotely.
This system enables medical professionals to access vital diagnostic insights even when the patient is outside a traditional clinical setting. ECG readings are transmitted wirelessly from the device to a patient's smartphone, which then relays this information to a sophisticated, cloud-based expert software system for analysis.
Branislav Vajdic established this Santa Clara, California-headquartered company in 2015.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for HeartBeam, Inc., and the rating behind it. BEATW last traded at $0.02; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for HeartBeam, Inc.. Starting points for HeartBeam, Inc.: EPS -$0.38, beta 0.89 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for HeartBeam, Inc.. HeartBeam, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for HeartBeam, Inc.. Trailing twelve-month EPS for HeartBeam, Inc. stands at -$0.38. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for HeartBeam, Inc.. HeartBeam, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
HeartBeam, Inc. valued side by side against its closest peers. HeartBeam, Inc. is measured against Medical - Specialties peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold HeartBeam, Inc., and how their positions are changing. At a $11.9M market value, institutional positions materially move HeartBeam, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by HeartBeam, Inc. executives and directors. Shares of HeartBeam, Inc. have traded between $0.01 and $0.29 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming HeartBeam, Inc.. HeartBeam, Inc. is a $11.9M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming HeartBeam, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for HeartBeam, Inc.. Coverage tracks HeartBeam, Inc. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.